Related Experiment Video

Updated: May 13, 2026

A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies
06:53

A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies

Published on: July 4, 2017

Fibroblast growth factor-2, bone homeostasis and fracture repair

Yurong Fei1, Gloria Gronowicz, Marja M Hurley

  • 1Department of Medicine, University of Connecticut School of Medicine, 263 Farmington Ave., Farmington, CT 06030, USA. hurley@nso1.uchc.edu

Current Pharmaceutical Design
|February 26, 2013
PubMed

Insights

Recombinant human fibroblast growth factor 2 (FGF-2) shows potential for treating bone defects and fractures. FGF-2 influences bone formation and healing through various signaling pathways, offering therapeutic possibilities.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Orthopedics

Background:

  • Critical size bone defects and non-union fractures require novel therapeutic strategies.
  • Recombinant human fibroblast growth factor 2 (FGF-2) is a potential agent for bone regeneration.

Purpose of the Study:

  • To discuss the function of FGF-2 in bone metabolism and fracture healing.
  • To review the role of exogenous FGF-2 in fracture repair.
  • To explore FGF-2 signaling crosstalk with other key pathways in bone formation.

Main Methods:

  • Literature review of FGF-2 function in bone formation, resorption, and signaling.
  • Analysis of FGF-2's role in fracture healing, including response to PTH and BMP2.
  • Examination of FGF-2 signaling crosstalk with Wnt and PTH pathways.

Main Results:

  • FGF-2 plays a role in bone formation and resorption.
  • Exogenous FGF-2 has potential therapeutic applications in fracture healing.
  • FGF-2 signaling interacts with Wnt and PTH pathways, influencing bone repair.

Conclusions:

  • FGF-2 is a promising therapeutic agent for bone regeneration.
  • Understanding FGF-2's signaling pathways is crucial for its clinical application.
  • Further research is needed to address unresolved issues in FGF-2 therapy for bone defects.

More Related Videos

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate10:32

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate

Published on: May 19, 2023

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice06:10

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice

Published on: September 16, 2020

Related Concept Videos

Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...